This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cancer Neoantigen Vaccines

BOOKING CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
February 2, 2023 | 1-Day Digital Conference
Digital Conference8:00AM EST // 1:00PM GMT // 2:00PM CET

February 2, 2023 | 1-Day Digital Conference
Digital Conference,
8:00AM EST // 1:00PM GMT // 2:00PM CET

FOCUS // Highly Focused Topics Delivered in a Digital Format

A digital format designed to bring you the latest Caner Neoantigen Vaccine updates from key players

Cut through the noise and dive into the topics that matter to you, on our best-in-class digital platform

A tour of the Digital Platform

Our best-in-class ConnectMe digital event platform makes it easier than ever for you to access today's leading science, technologies and networking opportunities within the Cancer Neoantigen community.

WHAT'S INCLUDED WITH YOUR DIGITAL EXPERIENCE PASS?

The digital experience features the same world-class content, collaboration and senior decision makers that we always provide, without the need to travel.

Access to the ConnectMe digital event platform starting 1 week before the event begins

Access to the content on-demand for 10 working days post-event

Access to the full attendee list with video chat, instant message and meeting request functionalities

Exposure to like-minded thought-leaders in the field to help expand your network

What to Expect

One-to-one Meetings

Access and engage with hundreds of potential partners using video chat, instant message and meeting request functionalities through our digital platform ConnectMe.

Insightful program

Deep dive into vaccine development.

Company Presentations

Attendees will have the opportunity to hear from and meet some of the industry's most talented biotechnology entrepreneurs and pharmaceutical leaders.